The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Self-citationCost-Effectiveness in Health and Medicine
(2016) · doi:10.1093/acprof:oso/9780190492939.001.0001 · Cited by 1,552
Economic Productivity by Age and Sex: 2007 Estimates for the United States
Grosse, S. D., Krueger, K. V., & Mvundura, M. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819c9571 · Cited by 115
Cited by
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
Greenberg, P., Chitnis, A., Louie, D., Suthoff, E., Chen, S.-Y., Maitland, J., Gagnon-Sanschagrin, P., Fournier, A.-A., & Kessler, R. C. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02622-x · Cited by 223
Lakdawalla, D. N., & Phelps, C. E. (2021) · Value in Health · doi:10.1016/j.jval.2020.10.003 · Cited by 120
Self-citationSharma, S., Hucker, A., Matthews, T., Grohmann, D., & Laws, K. R. (2021) · BMC Psychology · doi:10.1186/s40359-021-00658-8 · Cited by 109
Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy
Drummond, M. F., Neumann, P. J., Sullivan, S. D., Fricke, F.-U., Tunis, S., Dabbous, O., & Toumi, M. (2019) · Value in Health · doi:10.1016/j.jval.2019.03.012 · Cited by 92
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
Coyle, D., Durand-Zaleski, I., Farrington, J., Garrison, L., Graf von der Schulenburg, J.-M., Greiner, W., Longworth, L., Meunier, A., Moutié, A.-S., Palmer, S., et al. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01212-w · Cited by 71
Self-citationO'Brien, G. L., O'Mahony, C., Cooke, K., Kinneally, A., Sinnott, S.-J., Walshe, V., Mulcahy, M., & Byrne, S. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.01.011 · Cited by 29
Herring, W. L., Gallagher, M. E., Shah, N., Morse, K., Mladsi, D., Dong, O. M., Chawla, A., Leiding, J. W., Zhang, L., Paramore, C., et al. (2024) · PharmacoEconomics · doi:10.1007/s40273-024-01385-9 · Cited by 18
“…considered co-base-case analyses from both a US third-party payer perspective (including patient health outcomes and direct medical costs only) and a US societal perspective (including caregiver quality-of-life impacts and indirect costs related to productivity loss and unpaid caregiving) [37–39].”
Characterizing attributes of innovation of technologies for healthcare: a systematic review
Syeed, M. S., Poudel, N., Ngorsuraches, S., Veettil, S. K., & Chaiyakunapruk, N. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2140591 · Cited by 18
Willmington, C., Kirby, A., & Murphy, A. (2025) · Health Economics Review · doi:10.1186/s13561-025-00707-7
“Some argue that other factors may also contribute to the value of ATMPs to patients and society include hope, an unmet need addressed, perceived inno-vativeness and the intervention’s propensity to transform the lives of patients and their carers [78, 85–87].”
Metadata
- Authors
- Lakdawalla, D. N., Doshi, J. A., Garrison, L. P., Phelps, C. E., Basu, A., & Danzon, P. M.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 21
- Issue
- 2
- Pages
- 131-139
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2788249140
- Cited by
- 540
- References
- 4
- FWCI
- 69.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
